Table 2.
Relation between telomerase activity and hTERT expression and clinical pathologic factors of colorectal carcinoma
| Group | n | Telomerase (%) | hTRET (%) |
| Dukes’ A | 0 | 0 | 0 |
| Dukes’ B | 2 | 1/2a | 1/2a |
| Dukes’ C | 24 | 83.33 (20/24) | 83.33 (20/24) |
| Dukes’ D | 4 | 4/4a | 2/4a |
| High differentiation | 5 | 2/5a | 3/5a |
| Moderate differentiation | 8 | 6/8a | 5/8a |
| Poor differentiation | 17 | 100.00 (17/17) | 88.24 (15/17) |
| With lymphatic metastasis | 10 | 80.00 (8/10)b | 70.00 (7/10)b |
| Without lymphatic metastasis | 20 | 0.00 (0/20) | 5.00 (1/20) |
a
indicates cases less than 10 not included in the percentage;
b
P<0.01 vs the group without lymphatic metastasis